These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11179252)

  • 1. Who should take aspirin for primary prophylaxis of coronary heart disease?
    Lowe GD
    Heart; 2001 Mar; 85(3):245-6. PubMed ID: 11179252
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on aspirin. People with heart disease should take aspirin; the decision is trickier for those without it.
    Harv Heart Lett; 2011 Aug; 21(12):3. PubMed ID: 21991607
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin as preventive therapy in patients with asymptomatic vascular disease.
    Berger JS
    JAMA; 2010 Mar; 303(9):880-2. PubMed ID: 20197537
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice.
    Mora S; Ames JM; Manson JE
    JAMA; 2016 Aug; 316(7):709-10. PubMed ID: 27323335
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriate aspirin use for primary prevention of cardiovascular disease.
    Miser WF
    Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 10. Should patients stop taking aspirin for primary prevention?
    Depta JP; Bhatt DL
    Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin use for primary prevention in elderly patients.
    Terrosu P
    Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
    Mutter J; Grandy R; Hulkower S; Stigleman S
    J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for Primary Prevention Reduces Cardiovascular Events, Increases Bleeding Risk.
    Rosenberg K
    Am J Nurs; 2019 May; 119(5):66. PubMed ID: 31033560
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.
    De Caterina R
    Ital Heart J; 2003 Apr; 4(4):228-31. PubMed ID: 12784774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case against routine aspirin use for primary prevention in low-risk adults.
    Bailey AL; Smyth SS; Campbell CL
    Am Fam Physician; 2011 Jun; 83(12):1387-90. PubMed ID: 21671539
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Fortuni F; Crimi G; Gritti V; Mirizzi AM; Leonardi S; Ferrari GM
    Eur J Prev Cardiol; 2019 Oct; 26(15):1677-1679. PubMed ID: 30744399
    [No Abstract]   [Full Text] [Related]  

  • 18. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspirin in the primary prevention of coronary disease. Is it good for everybody?].
    Lama A; Vega J
    Rev Med Chil; 2004 Jul; 132(7):886-8. PubMed ID: 15379339
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of aspirin as antiaggregant therapy in primary prevention. An update.
    Jiménez-García N; de la Torre Lima J; García Alegría J
    Med Clin (Barc); 2019 Oct; 153(8):326-331. PubMed ID: 31521369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.